Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy
Nastasia Wilfinger(Comprehensive Cancer Center Vienna), Karin Nowikovsky(University of Veterinary Medicine Vienna)
Cited by 31
Related Papers
TMBIM5 is the Ca2+/H+ antiporter of mammalian mitochondria
|EMBO Reports|2022|59